{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:00:59Z","timestamp":1758816059162},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T00:00:00Z","timestamp":1332201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10147-012-0400-1","type":"journal-article","created":{"date-parts":[[2012,3,19]],"date-time":"2012-03-19T05:38:27Z","timestamp":1332135507000},"page":"554-555","source":"Crossref","is-referenced-by-count":13,"title":["Does long-term treatment with Doxil\u00ae predispose patients to oral cancer?"],"prefix":"10.1007","volume":"18","author":[{"given":"Yehuda","family":"Ben-David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Leiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Kachta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad Abu","family":"El-Naaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,20]]},"reference":[{"key":"400_CR1","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","volume":"28","author":"E Pujade-Lauraine","year":"2010","unstructured":"Pujade-Lauraine E, Wagner U, Aavall-Lundquist E et al (2010) Pegylated liposomal doxorubicin and carboplatin compared with paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse. J Clin Oncol 28:3323\u20133329","journal-title":"J Clin Oncol"},{"issue":"17","key":"400_CR2","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.2000.18.17.3093","volume":"18","author":"AN Gordon","year":"2000","unstructured":"Gordon AN, Granai CO, Rose PG (2000) Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer. J Clin Oncol 18(17):3093\u20133100","journal-title":"J Clin Oncol"},{"issue":"9","key":"400_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/CAD.0b013e32833dc3c4","volume":"21","author":"T Grenader","year":"2010","unstructured":"Grenader T, Goldberg A, Gabizon A (2010) Monitoring long-term treatment with pegylated liposomal doxorubicin: how important is intensive cardiac follow-up? Anticancer Drugs 21(9):868\u2013871","journal-title":"Anticancer Drugs"},{"issue":"4","key":"400_CR4","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/annonc\/mdl484","volume":"18","author":"E Andreopolou","year":"2007","unstructured":"Andreopolou E, Gaiotti D, Kim E et al (2007) Pegylated liposomal doxorubicin HCL (PLD; Caelyx\/Doxil): experience with long-term maintenance in responding patients with re-current epithelial ovarian cancer. Ann Oncol 18(4):716\u2013721","journal-title":"Ann Oncol"},{"key":"400_CR5","doi-asserted-by":"crossref","unstructured":"Cannon TL, Muggia F, Hirsch D, Andreopoulou EA, Kerr AR, DeLacure MD (2011) Multiple cases of squamous cell carcinoma of the tongue and oral cavity in patients treated with long-term pegylated liposomal doxorubicin (PLD) for ovarian cancer. J Clin Oncol 29(suppl) (abstr 5557)","DOI":"10.1200\/jco.2011.29.15_suppl.5557"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-012-0400-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0400-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T18:24:58Z","timestamp":1561487098000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-012-0400-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,20]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1007\/s10147-012-0400-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,20]]}}}